SOAT1 and metabolic dysfunction-associated steatotic liver disease: The results showed that the differentially expressed RNAs were enriched in multiple pathways, i.e., Parkinson’s disease, ribosome, thermogenesis, oxidative phosphorylation, renal cell carcinoma, hepatocellular carcinoma, non-alcoholic fatty liver disease (NAFLD), chemokine signaling pathway, and Jak-STAT signaling pathway (Figure 5A and Supplementary Table 1).